Xu Cong Claireinsider trades

In SEC Form 4 filings, Xu Cong Claire is listed as EVP, Clinical Development of NovaBridge Biosciences (NBP). In the last 90 days, Xu Cong Claire sold $2.6K of NovaBridge Biosciences (NBP) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
NBPNovaBridge Biosciences	EVP, Clinical Development	3	Sep 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NBPNovaBridge Biosciences	Aug 31	Sep 1	S	3,282	$0.79	Sale −$2,593	304,201	No	Form 4
NBPNovaBridge Biosciences	Aug 30	Sep 1	M	9,382	not reported	not reported	307,483	No	Form 4
NBPNovaBridge Biosciences	Aug 30	Sep 1	M · derivative	4,079	$0.00	$0	28,558	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.